Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOXYNE LIMITED Director's Dealing 2007

May 31, 2007

64594_rns_2007-05-31_c26f2a53-ec96-4a24-a9e9-e7ed6963b36a.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

www.probiomics.com.au

Australian Stock Exchange limited, SYDNEY

Via: asxonline

Dear Sirs,

This is to advise that the following UNLISTED options have been issued to a Director, as approved at a general meeting of shareholders held on 21 September 2006.

CLASS EXERCISE PRICE NO OF OPTIONS
PCCAW – Unlisted employee options
expiring 14 September 2008
\$0.10 125.000

Yours sincerely,

Anostin

Paul B Magoffin, Company Secretary, 1 June 2007

Probiomics Limited (formally VRI BioMedical Limited)

Problomics Limited ACN 084 464 193 ABN 97 084 464 193 Suite G09 1 Central Avenue, Australian Technology Park, Eveleigh, Sydney NSW 1430, Australia Phone: +61 2 9209 4268 Fax: +61 2 9209 4256